Show Parent

September

ERJ Podcast Eur Respir J 2013; 42: E33
Respiratory health and disease in Europe: the new European Lung White Book G. John Gibson, Robert Loddenkemper, Bo Lundbäck, Yves Sibille Eur Respir J 2013; 42: 559-563
The European Respiratory Society fellowship programme: supporting young careers and building networks Robert Bals, Josephine Ricou Yanmaz, Céline Schaffter, Carine Pannetier, Nadia Kamel, Roelinde Middelveld, Sven-Erik Dahlén, Bart N. Lambrecht, Benoit Nemery, Laurent Nicod, Stephen Holgate Eur Respir J 2013; 42: 564-567
Thoracic Oncology HERMES syllabus: setting the basis for thoracic oncology training in Europe Fernando Gamarra, Paolo Boffetta, Dirk De Ruysscher, Enriqueta Felip, Mina Gaga, Bogdan Grigoriu, Rudolf M Huber, Sam M Janes, Charles Hugo Marquette, Gilbert Massard, Julie-Lyn Carrillo Noel, Jean-Paul Sculier, Anne-Pascale Meert Eur Respir J 2013; 42: 568-571
Indicator condition-guided HIV testing in Europe: a step forward to HIV control Francesco Blasi, Alberto Matteelli Eur Respir J 2013; 42: 572-575
Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Vincent Cottin, Athol Wells Eur Respir J 2013; 42: 576-579
Registries for paediatric pulmonary hypertension Georg Hansmann, Marius M. Hoeper Eur Respir J 2013; 42: 580-583
Tiotropium Respimat increases the risk of mortality: pro Richard Beasley Eur Respir J 2013; 42: 584-589
Tiotropium Respimat increases the risk of mortality: con Eric D. Bateman Eur Respir J 2013; 42: 590-593
Chronic burden of near-roadway traffic pollution in 10 European cities (APHEKOM network) Laura Perez, Christophe Declercq, Carmen Iñiguez, Inmaculada Aguilera, Chiara Badaloni, Ferran Ballester, Catherine Bouland, Olivier Chanel, Francisco B. Cirarda, Francesco Forastiere, Bertil Forsberg, Daniela Haluza, Britta Hedlund, Koldo Cambra, Marina Lacasaña, Hanns Moshammer, Peter Otorepec, Miguel Rodríguez-Barranco, Sylvia Medina, Nino Künzli Eur Respir J 2013; 42: 594-605
Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD Katia M.C. Verhamme, Ana Afonso, Silvana Romio, Bruno C. Stricker, Guy G.O. Brusselle, Miriam C.J.M. Sturkenboom Eur Respir J 2013; 42: 606-615
Lung function indices for predicting mortality in COPD Afroditi K. Boutou, Dinesh Shrikrishna, Rebecca J. Tanner, Cayley Smith, Julia L. Kelly, Simon P. Ward, Michael I. Polkey, Nicholas S. Hopkinson Eur Respir J 2013; 42: 616-625
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD Gianna Camiciottoli, Francesca Bigazzi, Matteo Paoletti, Lucia Cestelli, Federico Lavorini, Massimo Pistolesi Eur Respir J 2013; 42: 626-635
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort Alvar Agusti, Lisa D. Edwards, Bartolomé Celli, William MacNee, Peter M. A. Calverley, Hana Müllerova, David A. Lomas, Emiel Wouters, Per Bakke, Steve Rennard, Courtney Crim, Bruce E. Miller, Harvey O. Coxson, Julie C. Yates, Ruth Tal-Singer, Jørgen Vestbo Eur Respir J 2013; 42: 636-646
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification Paul W. Jones, Lukasz Adamek, Gilbert Nadeau, Norbert Banik Eur Respir J 2013; 42: 647-654
Risk of deep vein thrombosis and pulmonary embolism in asthma Christof J. Majoor, Pieter W. Kamphuisen, Aeilko H. Zwinderman, Anneke ten Brinke, Marijke Amelink, Lucia Rijssenbeek-Nouwens, Peter J. Sterk, Harry R. Büller, Elisabeth H. Bel Eur Respir J 2013; 42: 655-661
Transcriptome sequencing (RNA-Seq) of human endobronchial biopsies: asthma versus controls Ching Yong Yick, Aeilko H. Zwinderman, Peter W. Kunst, Katrien Grünberg, Thais Mauad, Annemiek Dijkhuis, Elisabeth H. Bel, Frank Baas, René Lutter, Peter J. Sterk Eur Respir J 2013; 42: 662-670
Sniff nasal inspiratory pressure in the longitudinal assessment of young Duchenne muscular dystrophy children Véronique Nève, Jean-Marie Cuisset, Jean-Louis Edmé, Alain Carpentier, Mike Howsam, Olivier Leclerc, Régis Matran Eur Respir J 2013; 42: 671-680
Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism Olivier Sanchez, Ludovic Trinquart, Benjamin Planquette, Francis Couturaud, Franck Verschuren, Vincent Caille, Nicolas Meneveau, Gérard Pacouret, Pierre-Marie Roy, Marc Righini, Arnaud Perrier, Laurent Bertoletti, Florence Parent, Christine Lorut, Guy Meyer Eur Respir J 2013; 42: 681-688
Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice Maurice Beghetti, Rolf M.F. Berger, Ingram Schulze-Neick, Ronald W. Day, Tomás Pulido, Jeffrey Feinstein, Robyn J. Barst, Tilman Humpl Eur Respir J 2013; 42: 689-700
Multidrug-resistant tuberculosis in children: evidence from global surveillance Matteo Zignol, Charalambos Sismanidis, Dennis Falzon, Philippe Glaziou, Masoud Dara, Katherine Floyd Eur Respir J 2013; 42: 701-707
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Andrea Pantoja, Christopher Fitzpatrick, Anna Vassall, Karin Weyer, Katherine Floyd Eur Respir J 2013; 42: 708-720
Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis Amr S. Albanna, Benjamin M. Smith, Deanna Cowan, Dick Menzies Eur Respir J 2013; 42: 721-732
Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults Thomas Bewick, Carmen Sheppard, Sonia Greenwood, Mary Slack, Caroline Trotter, Robert George, Wei Shen Lim Eur Respir J 2013; 42: 733-741
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Stefano Aliberti, Anna Maria Zanaboni, Tim Wiemken, Ahmed Nahas, Srinivas Uppatla, Letizia Corinna Morlacchi, Paula Peyrani, Francesco Blasi, Julio Ramirez Eur Respir J 2013; 42: 742-749
Prevalence and prognosis of unclassifiable interstitial lung disease Christopher J. Ryerson, Thomas H. Urbania, Luca Richeldi, Joshua J. Mooney, Joyce S. Lee, Kirk D. Jones, Brett M. Elicker, Laura L. Koth, Talmadge E. King, Jr, Paul J. Wolters, Harold R. Collard Eur Respir J 2013; 42: 750-757
Opioids for chronic refractory breathlessness: patient predictors of beneficial response Miriam J. Johnson, J. Martin Bland, Stephen G. Oxberry, Amy P. Abernethy, David C. Currow Eur Respir J 2013; 42: 758-766
Determinants of, and reference equation for, exhaled nitric oxide in the Chinese population Fanny W.S. Ko, Ting F. Leung, Gary W.K. Wong, Jojo H.Y. Chu, Hing Y. Sy, David S.C. Hui Eur Respir J 2013; 42: 767-775
Amelioration of hyperoxia-induced lung injury using a sphingolipid-based intervention Jeroen Tibboel, Stephen Joza, Irwin Reiss, Johan C. de Jongste, Martin Post Eur Respir J 2013; 42: 776-784
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination Roland Diel, Robert Loddenkemper, Jean-Pierre Zellweger, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marieke J. van der Werf, Masoud Dara, Anne Detjen, Peter Gondrie, Lee Reichman, Francesco Blasi, Giovanni Battista Migliori on behalf of the European Forum for TB Innovation Eur Respir J 2013; 42: 785-801
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Dominic Burg, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanovi?, the U-BIOPRED Study Group Eur Respir J 2013; 42: 802-825
Climate change, extreme weather events, air pollution and respiratory health in Europe M. De Sario, K. Katsouyanni, P. Michelozzi Eur Respir J 2013; 42: 826-843
Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Martine Loeve, Gabriel P. Krestin, Margaret Rosenfeld, Marleen de Bruijne, Stephen M. Stick, Harm A. Tiddens Eur Respir J 2013; 42: 844-857
Sex-related differences in respiratory symptoms: results from the BOLD Study Bernd Lamprecht, Lowie E. Vanfleteren, Michael Studnicka, Michael Allison, Mary Ann McBurnie, William M. Vollmer, Wan Cheng Tan, Rune Nielsen, Pawel Nastalek, Louisa Gnatiuc, Bernhard Kaiser, Christer Janson, Emiel F.M. Wouters, Peter Burney, A. Sonia Buist for the BOLD collaborative research group Eur Respir J 2013; 42: 858-860
Do we need bacteriological confirmation of cure in uncomplicated tuberculosis? Abbey Ursula Leahy, Marc Lipman, Martin Hetzel, Onn Min Kon, Susan Hopkins, and Ibrahim Abubakar Eur Respir J 2013; 42: 860-863
Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea Frédéric Gagnadoux, Marc Le Vaillant, Audrey Paris, Thierry Pigeanne, Sylvaine Chollet, Philippe Masson, Acya Bizieux-Thaminy, Marie-Pierre Humeau, Nicole Meslier, The IRSR sleep cohort group Eur Respir J 2013; 42: 863-866
Severe acute respiratory distress syndrome due to ipilimumab Daniel Franzen, Karin Schad, Reinhard Dummer, Erich W. Russi Eur Respir J 2013; 42: 866-868
Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition Joanne A. Groeneveldt, Steven J.M. Gans, Harm J. Bogaard, Anton Vonk-Noordegraaf Eur Respir J 2013; 42: 869-870
A case of resistance beyond extensively drug-resistant tuberculosis in Japan Hajime Kanamori, Bine Uchiyama, Satoshi Mitarai, Takashi Hatakeyama, Noboru Aso, Mitsuo Kaku Eur Respir J 2013; 42: 870-872
A case of resistance beyond extensively drug-resistant tuberculosis in Japan Giovanni Battista Migliori, Rosella Centis, Lia D'Ambrosio Eur Respir J 2013; 42: 872-873
Admissions and patterns of mechanical ventilation of critical COPD: an old and common friend, are we still prepared? Antonio M. Esquinas, Markus Stein Eur Respir J 2013; 42: 873-874